Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025Clinical and Experimental PediatricsOpen Access

Less invasive surfactant administration versus intubationsurfactant- extubation: a single-center retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJithin CSANA. NalinaASA. Shashidhar

Discussion

Loading...

Member takes

Overview

Retrospective study shows less invasive surfactant administration reduces intubation needs in preterm infants with RDS, suggesting improved outcomes.

Key Points

  • LISA significantly reduced the need for intubation and mechanical ventilation within 72 hours compared to InSurE.
  • The LISA group had an intubation rate of 18% versus 64% in the InSurE group, with a relative risk of 0.28.
  • This retrospective observational study spanned five years, involving preterm neonates with RDS at 24-34 weeks' gestation.
  • LISA demonstrated benefits in reducing invasive ventilation duration, although no significant differences were observed in secondary outcomes.

Cite This Study

CS et al. (2025) studied this question.

synapsesocial.com/papers/68e034f7f0e39f13e7fa337chttps://doi.org/10.3345/cep.2025.00332
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Systematic Review: Is LISA as Effective as Endotracheal Tube Surfactant Administration in Reducing Bronchopulmonary Dysplasia in Preterm Infants?2025
  2. 2Tiny Lungs, Big Decisions: A Meta‐Analysis Comparing Minimally Invasive Surfactant Therapy Versus Intubation–Surfactant–Extubation in Preterm Neonates With Respiratory Distress Syndrome2025 · 5 citations
  3. 3Factors Associated with Intubation After Less Invasive Surfactant Administration (LISA); A Single-Center Cohort from Saudi Arabia2025
  4. 4Comparison of Bovine Lipid Extract Surfactant and Poractant Alfa Administered via LISA in Preterm Infants(28<sup>+0</sup> to 34<sup>+6</sup> Week) With Respiratory Distress Syndrome: A Randomized Controlled Trial2025
  5. 5Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in ≥ 35 Weeks Gestational Age Infants.2025